FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2165902011> ?p ?o ?g. }

• W2165902011 endingPage "1219" @default.
• W2165902011 startingPage "1212" @default.
• W2165902011 abstract "Background We have previously performed retrospective analysis of patients with anaplastic thyroid carcinoma (ATC) treated between April 1976 and March 1999, revealing acute symptoms, large tumor (>5 cm), distant metastasis, and leukocytosis ≥10,000/mm3 as the most important prognostic factors. We devised a novel prognostic index (PI) as the total number of these 4 factors present, giving a PI of 0–4. Methods We have adopted this PI since April 1999. In principle, multimodal treatment has been encouraged for a PI of ≤1, whereas aggressive treatment has been avoided to maintain quality of life for a PI of ≥3. The validity of this therapeutic strategy was prospectively investigated in 74 patients with ATC. Results Six-month survival rates for PI ≤ 1 and PI ≥ 3 were 72% and 12%, respectively. Among patients with a PI of ≤1,11 (42%) underwent multimodal treatment and showed significantly better survival than previous cases. Survival rates did not differ between stages. For patients with a PI of ≥3, survival rates were equally dismal, regardless of stage. Numbers of patients who underwent tracheostomy or died from local disease were significantly decreased compared with previous cases. Conclusion Our PI is valid for anticipating prognosis and aiding timely decisions on treatment policy for ATC patients. We have previously performed retrospective analysis of patients with anaplastic thyroid carcinoma (ATC) treated between April 1976 and March 1999, revealing acute symptoms, large tumor (>5 cm), distant metastasis, and leukocytosis ≥10,000/mm3 as the most important prognostic factors. We devised a novel prognostic index (PI) as the total number of these 4 factors present, giving a PI of 0–4. We have adopted this PI since April 1999. In principle, multimodal treatment has been encouraged for a PI of ≤1, whereas aggressive treatment has been avoided to maintain quality of life for a PI of ≥3. The validity of this therapeutic strategy was prospectively investigated in 74 patients with ATC. Six-month survival rates for PI ≤ 1 and PI ≥ 3 were 72% and 12%, respectively. Among patients with a PI of ≤1,11 (42%) underwent multimodal treatment and showed significantly better survival than previous cases. Survival rates did not differ between stages. For patients with a PI of ≥3, survival rates were equally dismal, regardless of stage. Numbers of patients who underwent tracheostomy or died from local disease were significantly decreased compared with previous cases. Our PI is valid for anticipating prognosis and aiding timely decisions on treatment policy for ATC patients." @default.
• W2165902011 created "2016-06-24" @default.
• W2165902011 creator A5032684712 @default.
• W2165902011 creator A5054590525 @default.
• W2165902011 creator A5087410964 @default.
• W2165902011 creator A5090700584 @default.
• W2165902011 date "2011-12-01" @default.
• W2165902011 modified "2023-09-25" @default.
• W2165902011 title "Prospective application of our novel prognostic index in the treatment of anaplastic thyroid carcinoma" @default.
• W2165902011 cites W1991360638 @default.
• W2165902011 cites W1996308728 @default.
• W2165902011 cites W1998915601 @default.
• W2165902011 cites W2007195565 @default.
• W2165902011 cites W2010787970 @default.
• W2165902011 cites W2014737046 @default.
• W2165902011 cites W2019281142 @default.
• W2165902011 cites W2020301583 @default.
• W2165902011 cites W2025906248 @default.
• W2165902011 cites W2028403577 @default.
• W2165902011 cites W2033980810 @default.
• W2165902011 cites W2047629074 @default.
• W2165902011 cites W2068784175 @default.
• W2165902011 cites W2102052231 @default.
• W2165902011 cites W2144064311 @default.
• W2165902011 cites W2163927493 @default.
• W2165902011 cites W2168072877 @default.
• W2165902011 doi "https://doi.org/10.1016/j.surg.2011.09.005" @default.
• W2165902011 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22136842" @default.
• W2165902011 hasPublicationYear "2011" @default.
• W2165902011 type Work @default.
• W2165902011 sameAs 2165902011 @default.
• W2165902011 citedByCount "28" @default.
• W2165902011 countsByYear W21659020112012 @default.
• W2165902011 countsByYear W21659020112013 @default.
• W2165902011 countsByYear W21659020112014 @default.
• W2165902011 countsByYear W21659020112015 @default.
• W2165902011 countsByYear W21659020112016 @default.
• W2165902011 countsByYear W21659020112018 @default.
• W2165902011 countsByYear W21659020112019 @default.
• W2165902011 countsByYear W21659020112020 @default.
• W2165902011 countsByYear W21659020112021 @default.
• W2165902011 countsByYear W21659020112022 @default.
• W2165902011 countsByYear W21659020112023 @default.
• W2165902011 crossrefType "journal-article" @default.
• W2165902011 hasAuthorship W2165902011A5032684712 @default.
• W2165902011 hasAuthorship W2165902011A5054590525 @default.
• W2165902011 hasAuthorship W2165902011A5087410964 @default.
• W2165902011 hasAuthorship W2165902011A5090700584 @default.
• W2165902011 hasConcept C121608353 @default.
• W2165902011 hasConcept C126322002 @default.
• W2165902011 hasConcept C141071460 @default.
• W2165902011 hasConcept C143998085 @default.
• W2165902011 hasConcept C146357865 @default.
• W2165902011 hasConcept C151730666 @default.
• W2165902011 hasConcept C167135981 @default.
• W2165902011 hasConcept C2777546739 @default.
• W2165902011 hasConcept C2778923028 @default.
• W2165902011 hasConcept C2778981773 @default.
• W2165902011 hasConcept C2779013556 @default.
• W2165902011 hasConcept C71924100 @default.
• W2165902011 hasConcept C86803240 @default.
• W2165902011 hasConcept C90924648 @default.
• W2165902011 hasConceptScore W2165902011C121608353 @default.
• W2165902011 hasConceptScore W2165902011C126322002 @default.
• W2165902011 hasConceptScore W2165902011C141071460 @default.
• W2165902011 hasConceptScore W2165902011C143998085 @default.
• W2165902011 hasConceptScore W2165902011C146357865 @default.
• W2165902011 hasConceptScore W2165902011C151730666 @default.
• W2165902011 hasConceptScore W2165902011C167135981 @default.
• W2165902011 hasConceptScore W2165902011C2777546739 @default.
• W2165902011 hasConceptScore W2165902011C2778923028 @default.
• W2165902011 hasConceptScore W2165902011C2778981773 @default.
• W2165902011 hasConceptScore W2165902011C2779013556 @default.
• W2165902011 hasConceptScore W2165902011C71924100 @default.
• W2165902011 hasConceptScore W2165902011C86803240 @default.
• W2165902011 hasConceptScore W2165902011C90924648 @default.
• W2165902011 hasIssue "6" @default.
• W2165902011 hasLocation W21659020111 @default.
• W2165902011 hasLocation W21659020112 @default.
• W2165902011 hasOpenAccess W2165902011 @default.
• W2165902011 hasPrimaryLocation W21659020111 @default.
• W2165902011 hasRelatedWork W1586374228 @default.
• W2165902011 hasRelatedWork W2003938723 @default.
• W2165902011 hasRelatedWork W2047967234 @default.
• W2165902011 hasRelatedWork W2118496982 @default.
• W2165902011 hasRelatedWork W2364998975 @default.
• W2165902011 hasRelatedWork W2369162477 @default.
• W2165902011 hasRelatedWork W2439875401 @default.
• W2165902011 hasRelatedWork W4238867864 @default.
• W2165902011 hasRelatedWork W4253073611 @default.
• W2165902011 hasRelatedWork W2525756941 @default.
• W2165902011 hasVolume "150" @default.
• W2165902011 isParatext "false" @default.
• W2165902011 isRetracted "false" @default.
• W2165902011 magId "2165902011" @default.
• W2165902011 workType "article" @default.